In conclusion, this study could not confirm our hypothesis that anti-oxidative therapy with pravastatin and vitamin E increases α-Klotho concentrations in patients with mild-moderate CKD on background therapy with ACE-inhibitors. This evidence concerns the gene KL and chronic kidney disease.